Patient INformation About Options for Treatment - PINOT (PINOT)
|ClinicalTrials.gov Identifier: NCT01298115|
Recruitment Status : Completed
First Posted : February 17, 2011
Last Update Posted : February 17, 2011
This prospective observational study is designed to find out what treatment options new patients with chronic kidney disease learn about from their renal unit.
Aims: To determine the proportion of new CKD patients who receive information about treatment options prior to commencing dialysis, pre−emptive transplantation or conservative management. To determine the timing (i.e. patient's stage of disease) when information is given. To find out whether patients have a friend or family member with them when information is given.
Research Design and methods: This study is an assessment of CKD education practices. Nephrologists and pre−dialysis coordinators from each renal unit will complete questionnaires about information that was given to each new dialysis, pre−emptive transplant or conservatively managed patient that started treatment during a 3 month period.
Study hypothesis: Approximately one third of CKD patients will receive information after starting treatment. There will be a positive association between in−centre haemodialysis and later referral, non−English speaking background, and advancing age. Significance: The results from this national audit will provide Australian nephrologists and renal nurses with evidence about CKD education practices and compliance with clinical practice guidelines. The results may highlight opportunities for improvement in practice.
|Condition or disease|
|Chronic Kidney Disease|
Additional research objectives and key research questions:
1. To determine the proportion of patients who receive information about: pre−emptive transplantation; peritoneal dialysis; home haemodialysis; centre based haemodialysis; supported non−dialytic care or conservative management.
3. To determine the proportion of incident patients that have a non−English speaking background (NESB) requiring an interpreter or translated materials.
4. To examine associations between age, gender, health insurance status, NESB, CKD stage and information provided on initial treatment commenced.
5. To determine the proportion of patients who choose not to dialyse.
|Study Type :||Observational|
|Actual Enrollment :||721 participants|
|Official Title:||Patient Information About Options for Treatment of Stage 5 Chronic Kidney Disease|
|Study Start Date :||July 2009|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||December 2010|
Stage 5 chronic kidney disease
Incident patients commencing renal replacement therapy or conservative care
- Proportion of incident Stage 5 CKD patients who receive information about their treatment options prior to commencing treatment [ Time Frame: Time prior to commencement of treatment. eg. 3 months ]
- Stage of CKD (based on eGFR) when information about treatment options is first given [ Time Frame: one time point prior to commencement of treatment ]
- Patient and unit characteristics associated with commencing renal replacement therapy versus conservative care [ Time Frame: One time point based on commencement date of first treatment ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01298115
|Australia, New South Wales|
|University of Sydney|
|Sydney, New South Wales, Australia, 2006|
|Study Chair:||Kirsten Howard, PhD||University of Sydney|